Michael A. Klobuchar

Companies

• Eikon Therapeutics, Inc.Chief operating officer Feb 4, 2026 to now¹
• Revvity Inc.Board member Feb 1, 2024 to now²
• Merck & Co.EVP - Chief Strategy Officer Jul 15, 2021 to May 6, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Merck & Co. MRK24,319 shares⁴$3.6M at $149.02May 6, 2024
• Revvity Inc. RVTY7,368 shares⁵$1.1M at $152.28May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 7, 2026Granted 1,265 shares of Revvity Inc.⁵
• May 7, 2026Granted 1,015 shares of Revvity Inc.⁵
• Apr 30, 2025Granted 1,338 shares of Revvity Inc.⁶
• Apr 30, 2025Granted 1,074 shares of Revvity Inc.⁶
• May 4, 2024Shares withheld for tax 437 shares at $127.51 of Merck & Co.⁴
• May 4, 2024Exercised options 887 shares at $127.51 of Merck & Co.⁴
• May 1, 2024Granted 1,218 shares of Revvity Inc.⁷
• May 1, 2024Granted 977 shares of Revvity Inc.⁷
• Feb 15, 2024Granted 264 shares of Revvity Inc.⁸
• Feb 15, 2024Granted 217 shares of Revvity Inc.⁸
• Jan 22, 2024Granted 3,896 shares at $119.43 of Merck & Co.⁹
• May 4, 2023Shares withheld for tax 436 shares at $118.22 of Merck & Co.¹⁰
• May 4, 2023Exercised options 885 shares at $118.22 of Merck & Co.¹⁰
• May 1, 2023Shares withheld for tax 427 shares at $115.47 of Merck & Co.¹¹
• May 1, 2023Exercised options 866 shares at $115.47 of Merck & Co.¹¹
• Jan 23, 2023Granted 2,651 shares at $109.88 of Merck & Co.¹²
• May 4, 2022Shares withheld for tax 436 shares at $87.10 of Merck & Co.¹³
• May 4, 2022Exercised options 885 shares at $87.10 of Merck & Co.¹³
• May 3, 2022Shares withheld for tax 381 shares at $87.65 of Merck & Co.¹⁴
• May 3, 2022Exercised options 773 shares at $87.65 of Merck & Co.¹⁴
• May 1, 2022Shares withheld for tax 427 shares at $88.69 of Merck & Co.¹⁵
• May 1, 2022Exercised options 866 shares at $88.69 of Merck & Co.¹⁵
• Feb 24, 2022Granted 2,994 shares at $73.51 of Merck & Co.¹⁶